Indutrade acquires med-tech company
Indutrade today acquired all of the shares in EssMed AB, in Mölnlycke, Sweden,
with annual sales of approximately SEK 60 million.
EssMed markets ophthalmology products and services. The company is a market
leader in sales of equipment to private and public sector ophthalmology
departments. EssMed also sells other medical products, including operation
microscopes and pressure relief devices. The company has a subsidiary in
Finland.
The acquisition of EssMed marks the entry into a new product segment for
Indutrade, in the pharmaceutical industry. Organisationally, EssMed will be
included in the Industrial Components business area, which had net sales of SEK
940 million in 2007.
The acquisition is expected to have a marginally positive impact on Indutrade's
earnings per share.
Stockholm, 19 March 2008
INDUTRADE AB (publ)
For further information, please contact:
Johnny Alvarsson, President and CEO, tel. +46-70 589 17 95.
About Indutrade
Indutrade markets and sells components, systems and services with a high-tech
content within selected niches. Indutrade's business is distinguished by:
• High-tech products for recurring needs
• Growth through a structured and tried-and-tested acquisition strategy
• A decentralised organisation characterised by an entrepreneurial spirit
The Group is structured into four business areas: Engineering & Equipment, Flow
Technology, Industrial Components and Special Products. Indutrade's sales
totalled SEK 5 673 million in 2007, generating operating income of SEK 650
million before depreciation of intangible assets. Indutrade is listed on the OMX
Nordic Exchange Stockholm.
